Fulgent Genetics (FLGT) stock
FLGT's Quality Score fell 7 points on Tue, Oct 6, to -1. Its moving averages fell out of order (5 chart checks stopped). 2 more reasons, for Pro members.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Since its Dec 2021 high
Down 79%, profit $507.4M → a $60.5M loss a year.
2 more reasons behind FLGT's -1, for Pro members
Why FLGT is down
Fulgent Genetics fell 8.3% on Oct 6; it filed no 8-K that day, and its industry fell a median 6.1%.
Services-Medical Laboratories stocks fell a median 6.1% that day; Fulgent Genetics fell 8.3%.
−1Profit Lost $84M over the last four quarters, more than the $51M lost a year earlier, from the SEC filings
1 more driver, the timeline, and the peer table, for Pro members
2 more things pulling FLGT's score down, for Pro members
What's next
Expected to report Fri Nov 6, after the close
After its last 4 reports it closed -11.3% on average, higher 1 of 4 times.
What would turn FLGT's score around: 7 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
FLGT has 2 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1445.9
- MACD (12, 26, 9)Below signal
- 50-day average$20.09
- 200-day average$19.95
- ADX 1426.0
- Support$19.20
- Resistance$21.52
- Bollinger Bands (20, 2)Inside
- Volume1.1x
How FLGT ranks in Diagnostics
FLGT is #16 of 17 by Quality Score among Services-Medical Laboratories. The top three are shown with their scores, and more by name.
CDNA4/1415
NTRA3/1414
CAI2/1410
CSTLOpen for its score
DGXOpen for its score
FTREOpen for its score
GHOpen for its score
FLGT2/14-1
When does FLGT report earnings, and what happens after?
Expected to report Fri Nov 6, after the close (in 31 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Jul 30, 2026After close | After close | -14.3% | -18.1% | -8.2% |
| May 1, 2026Before open | Before open | -7.6% | -7.0% | -0.5% |
| Feb 27, 2026Before open | Before open | -23.2% | -38.1% | -42.5% |
| Nov 7, 2025Before open | Before open | +7.8% | +18.1% | +32.6% |
Who is trading FLGT
FLGT insider trades
2 insiders sold $117K across 4 filings in the last 6 months. No open-market buys on record. The newest:
FLGT's officers and directors
Officers and directors with a Form 4 here in the last 3 months. Open one for their trades at every company.
About Fulgent Genetics
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of FLGT's score, with the points and the reason
- All 14 checks on FLGT and on all 3,244 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on FLGT
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.